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Chromatin isolated from Ehrlich ascites cells was incubated with the tumourigenic ompound (+)-7/?,8a-dihydroxy- 
9a,lOa-epoxy-7,8,9,10-tetrahydrobenz[a]pyrene [( +)-anti-BPDE] at low ionic strength and the modified chromatin was 
analysed using flow linear dichroism (LD). The results confirm that (+)-an&BPDE preferentially binds to the DNA 
in the linker regions, and furthermore show that the long axis of the bound pyrenyl chromophore is oriented parallel 
or close to parallel to the average orientation of the chromatin fiber axis. The data indicate that the binding geometry 
of (+)-anri-BPDE in chromatin is similar to that in pure DNA and deoxyguanosine-containing double-helical ohgo- 
nucleotides. 
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1. INTRODUCTION 
The tumourigenic process initiated by 
benz[a]pyrene (BP), a ubiquitous environmental 
contaminant, is believed to involve sequential ac- 
tivation of BP to ( + )-7@,8a-dihydroxy-9a, 10~ 
epoxy-7,8,9,10-tetrahydrobenz[a]pyrene ]( + )- 
anti-BPDE] and subsequent covalent binding of 
this intermediate through the benzoylic carbon 10 
to DNA (reviews [1,2]). Results from both in vitro 
and in vivo experiments have demonstrated that 
the major binding target in DNA is the exocyclic 
nitrogen of deoxyguanosine (dG) ([3] and 
references therein). Structural features of the ad- 
ducts resulting from incubating ( + )-anti-BPDE or 
the less tumourigenic isomers (e.g. (&)-syn- and 
(-)-anti-BPDE) with purified DNA or different 
oligonucleotides have been extensively studied in 
vitro and in vivo by various spectroscopic techni- 
ques [4,5]. From such studies it can be concluded 
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that DNA binding of ( + )-anti-BPDE results in dif- 
ferent types of complexes where the chromophores 
of the dominating fraction are oriented with their 
long axes parallel or close to parallel to the helix 
axis of DNA (defined as type II complexes, see 
[4,5]). In contrast, a major fraction of the bound 
chromophores of the less carcinogenic BPDE 
isomers is oriented more perpendicular to the helix 
axis of DNA, which is more compatible with the 
intercalation type of complexes (defined as type I 
complexes, see [4,5]). Systematic studies on the 
tumour-initiating potency of all possible bay- 
region diol epoxides of several polycyclic aromatic 
hydrocarbons have shown that the (+) enan- 
tiomers of the anti diastereomers in most cases are 
by far the most active forms [2]. Interestingly, 
available data from in vitro experiments how that 
DNA binding of these intermediates in general 
results in formation of type II complexes [4,6]. To 
our knowledge, there is, however, no information 
demonstrating the relevance of these findings in in 
vivo-like systems. In a first attempt o obtain struc- 
tural information, we have incubated isolated 
chromatin with (+)-anti-BPDE and analysed the 
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modified preparation by flow linear dichroism 
(LD). 
2. MATERIALS AND METHODS 
Micrococcal nuclease solubilized chromatin was isolated 
from nuclei of mouse Ehrlich ascites mouse tumour cells as in 
1161, and dialyzed vs 0.25 mM EDTA. The chromatin had the 
normal content of histones and an average size of 50 
nucleosomes. 
35-75 nmol (+)-anti-BPDE was dissolved in 50 pl ethanol 
immediately prior to addition to 2.5 ml of chromatin, or DNA, 
in 0.25 mM EDTA, pH 7.8 (3.0-3.6 A units/ml). The binding 
ratio, r, is defined as the number of bound chromophores per 
phosphate and was calculated using molar absorption coeffi- 
cients of 29000 M-“cm- at 346 nm for BPDE and 
6600 M-‘.cm-’ at 258 nm for chromatin and DNA. 
The experimental conditions for LD analysis have been 
described in earlier chromatin flow LD studies [13,17]. The LD 
spectrometer was operated according to the principles given in 
1181. 
3. RESULTS 
When adding (+)-rmti-BPDE to chromatin an 
LD signal arises immediately (within 2 min) in the 
absorption bands of the pyrenyl chromophore 
(fig. 1) showing that the diol epoxide is bound and 
oriented by the chromatin fiber. Both positive and 
negative absorption bands are observed in the 
300-370 nm region (corresponding to the L, tran- 
sition moment in the pyrene residue), indicating 
the presence of different populations of (+)-anti- 
BPDE-DNA complexes with more parallel and 
more perpendicular orientations, respectively, 
relative to the average fiber axis. Both the absorp- 
tion and LD features differ significantly from the 
spectra obtained with (+)-anti-BPDE incubated 
with pure DNA (obtained from the same 
chromatin batch). The predominant negative LD 
feature observed with DNA can be due to remain- 
ing ( + )-anti-BPDE being physically intercalated 
or, which is more likely, tetraols (BPTs) resulting 
from diol epoxide hydrolysis. The absorption spec- 
trum is also in support of a significant portion of 
BPTs being intercalated in DNA but not in the cor- 
responding chromatin sample. After dialysis (vs 
200 vols of 0.25 mM EDTA overnight) to remove 
the remaining, physically bound diol epoxide and 
tetraols, the LD spectrum became entirely positive 
(except for a weak negative contribution at 356 nm 
in the DNA sample due to the remaining inter- 
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Fig. 1. Absorption (A) and LD spectra of reaction mixtures (a) 
and dialysed solutions (b) of (+)-anti-BPDE and chromatin 
[r = 0.0069 (-)I, or DNA [r = 0.0044 (---)I. Reaction 
medium, 0.25 mM EDTA, pH 7.8, 8’C; flow gradient, 
1800 s-l. Neither of the LD spectra changed significantly with 
time (h). 
calated BPT, which vanished after further 
dialysis). 
The positive LD of (+)-anti-BPDE covalently 
bound to chromatin is consistent with the binding 
geometry observed for the DNA adduct, with the 
long axis of the pyrenyl chromophore oriented 
more or less parallel to the DNA helix axis [7,8]. 
Table 1 summarizes the LD values for the pyrene 
residue of (+)-anti-BPDE (346 nm) and for the 
DNA bases (258 nm) observed under different salt 
conditions in chromatin and in DNA. Table 1 also 
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Table 1 
LD’ and LD features of (+)-anti-BPDE covalently bound to 
chromatin or DNA= 
[NaCI] (+ )-anti-BPDE/ (+ )-anti-BPDE/ 
chromatin DNA 
(r = 0.0048) (f = 0.0044) 
LDiss OmM - 0.024 -0.137 
2.5 M - 0.050 - 0.053 
LD& OmM 0.036 0.136 
2.5 M 0.046 0.056 
LDs&LDzss OmM -0.031 - 0.019 
1 mM - 0.035 
2mM - 0.042 
5mM -0.071 
2.5 M -0.013 -0.021 
= LD’ = LD/A 
All measurements were performed at 8°C in medium 
comprising 0.25 mM EDTA (pH 7.8) plus the indicated 
additions of NaCl. Flow gradient, 1800 s-r. At 2.5 M NaCl the 
chromatin dissociates 
lists data for the ( + )-anti-BPDE-DNA sample re- 
maining after salt-induced dissociation of the 
histones. 
4. DISCUSSION 
The positive LD spectrum in the 300-350 nm 
region of (+)-anti-BPDE-modified chromatin is in 
qualitative agreement with preferential binding of 
the diol epoxide to linker DNA and with binding 
geometry similar to that in pure DNA. This con- 
clusion is supported by the fact that the ratio 
LDx~~(BPDE)/LDz~~(DNA) decreases by as much 
as a factor of 2.3 for chromatin when increasing 
the salt from 0 to 2.5 M (dissociation) compared to 
the constant ratio for the modified pure DNA. If 
the diol epoxide had been homogeneously 
distributed over nucleosomal and linker DNA, 
identical ratios would have been obtained (presum- 
ing the same local binding geometries). The 
enhancement in the LD of (+)-anti-BPDE is thus 
explained by a different orientation of the linker 
DNA vs the average DNA orientation. Previous 
experiments using BP or racemic anti-BPDE and 
chromatin have clearly demonstrated a pro- 
nounced preference for binding to DNA in the 
linker regions [9-121. 
Another interesting observation concerns the 
behaviour of the LD(BPDE)/LD(DNA) ratio 
when increasing the ionic strength moderately by 
addtion of NaCl. At very low ionic strength, 
chromatin is known to adopt an extended confor- 
mation, characterized by a strongly negative 
LD(DNA); the magnitude of this LD signal 
decreases drastically with increasing salt concen- 
tration and the LD of unmodified chromatin has 
been observed to change sign in the region of 
2-5 mM NaCl [13]. With (+ )-anti-BPDE- 
modified chromatin, the negative LD(DNA) 
amplitude similarly decreases with added salt and 
becomes positive, however, at a somewhat higher 
salt concentration (10 mM NaCI) than for un- 
modified chromatin. The LD(BPDE)/LD(DNA) 
ratio increases considerably when the salt concen- 
tration is increased (by a factor of 2 at 5 mM 
NaCl). Such behaviour would be expected if the 
nucleosomal and linker DNA regions contributed 
to differing extents to the LD for the various 
degrees of folding of the chromatin structure. In- 
deed, these results indicate that BPDE covalently 
bound to chromatin may be used as a sensitive 
probe of the conformation of the internucleosomal 
linker DNA of the chromatin fiber. Results concer- 
ning this aspect will appear elsewhere. 
It is worth noting that the kinetics of diol epox- 
ide binding to chromatin observed here are 
markedly more rapid than those reported by Dock 
and McLeod [14]. At the low ionic strength used 
here maximal amplitude of the LD(BPDE) is 
observed within 2 min after addition of the diol 
epoxide to the chromatin preparation, thus imply- 
ing that the reaction has proceeded to completion. 
Similar results were obtained in preliminary ex- 
periments where chromatin was incubated with 
tritiated ( + )-anti-BPDE at low salt concentration 
and the extent of covalent binding to DNA as well 
as to histones was determined as a function of time 
(15 s-30 min). Full details of these experiments 
will be given elsewhere. The results of Dock and 
McLeod [14] could be explained by the fact that 
they used spermine and spermidine in the 
chromatin preparation, which may lead to more 
condensed, and hence less penetrable structures 
[15], as demonstrated by the LD data for such 
preparations (not shown). These authors also used 
slightly higher salt concentrations (10 mM) and the 
polyamines may also react with the diol epoxide. 
Finally, the less negative LD for freshly reacted 
203 
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( + )-anti-BPDE with chromatin, compared to 
DNA, indicates lower amounts of intercalated 
non-covalently bound BPTs in chromatin. This is 
in agreement with the findings of Dock and 
McLeod [14]. 
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